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Cocaine use disorder (CUD) affects 17 million people worldwide. The success in
recovery from CUD is challenged by vulnerability to relapse driven in large part by cue
reactivity (sensitivity to cues previously linked with drug-taking experience) and craving.
Recently, the Cunningham group has demonstrated that the 5-HT2A receptor (5-HT2AR)
and the 5-HT2C receptor (5-HT2CR) have oppositional effects on cue reactivity.
Specifically, 5-HT2CR agonists and 5-HT2AR antagonists reduce cue reactivity in cocaine
self-administration supporting the idea of that these two receptors act in opposition to
control behaviors related to CUD. Previous work has demonstrated that higher expression
of the 5-HT2AR coupled with lower expression of the 5-HT2CR in the medial prefrontal
cortex (mPFC) is associated with heightened cue reactivity following a period of
abstinence. In addition to the mPFC, the hippocampus is another key brain region that
plays a critical role in the development of drug-cue associations. It is currently unknown
if the expression patterns of the 5-HT2AR and the 5-HT2CR are different along the dorsalventral axis of the hippocampus. Given the functional differences between the dorsal
(dHipp) and ventral hippocampus (vHipp), (i.e. the dHipp regulates cognitive functions
and vHipp regulates mood and anxiety), we tested the hypothesis that there would be an
increase in 5-HT2AR in the dHipp and an increase of the 5-HT2CR in the vHipp. We used
immunohistochemistry methods to detect 5-HT2AR and 5-HT2CR expressions in the
hippocampus in fixed rat brains. Our results indicate that vulnerability to relapse could be
driven by altered interactions of the 5-HT2CR and the 5-HT2AR within the hippocampus
formation.
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